Article
Presentation of EGFR mutations in 162 family probands with multiple primary lung cancer
1 Apr 2021
Abstract excerpt
Background: The number of multiple primary lung cancer (MPLC) patients has rapidly increased in recent years. However, information regarding the etiology of MPLC and responsiveness to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) is rare. The present study aims to describe the mutation signatures of EGFR in MPLC.Methods: Polymerase chain reaction (PCR) and Sanger sequencing were used...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
